Pain News and Research

Latest Pain News and Research

Primary-care clinic treatment improves patient follow up

Treating low-acuity emergency-department patients in a primary-care clinic results in better future primary care follow up, research shows.

14 Jan 2013

Viewpoints: Rove says GOP unlikely to make much 'structural change' to entitlements; Roe anniversary and fading public understanding; Fast food workers' health insurance

As a matter of policy, rather than politics, it is no more sensible to draw the line at $620 billion in additional revenue over the next decade than to insist, as have some Democrats, that Medicare and Social Security remain untouched. The country's structural deficit poses too large a threat to future prosperity, and there is no politically or fiscally realistic scenario under which entitlement cuts alone can solve the problem.

11 Jan 2013

LM11A-31 effective at improving limb movement after spinal cord injury in mice

An experimental oral drug given to mice after a spinal cord injury was effective at improving limb movement after the injury, a new study shows.

10 Jan 2013

CTI initiates enrollment in pacritinib Phase 3 trial for myelofibrosis

Cell Therapeutics, Inc. (CTI) today announced that the Company has initiated clinical trial sites and began enrolling patients in a Phase 3 clinical trial, known as PERSIST-1 or PAC325, for pacritinib, CTI's investigational JAK2 inhibitor, which is being evaluated for the treatment of patients with myelofibrosis.

9 Jan 2013

Chronic neck pain patients show respiratory weakness

Chronic neck pain appears to be associated with impaired respiratory function due to weakness of the respiratory muscles, study findings indicate.

8 Jan 2013

$Sonoma launches VELOX procedure for repairing clavicle fractures with Sonoma CRx device$

Sonoma launches VELOX procedure for repairing clavicle fractures with Sonoma CRx device

Sonoma Orthopedic Products, Inc. today announced the launch of its new VELOX procedure for repairing clavicle fractures with the Sonoma CRx clavicle nail.

8 Jan 2013

Spectrum Pharmaceuticals reveals positive RenaZorb Phase 1 clinical trial results

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced positive, statistically significant data from the Company's Phase 1 clinical trial evaluating the safety and tolerability of RenaZorb (also referred to as SPI-014) in healthy volunteers.

8 Jan 2013

Merck’s resubmission of the NDA for suggammadex sodium injection accepted for review by the FDA

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the resubmission of the New Drug Application (NDA) for sugammadex sodium injection has been accepted for review by the U.S. Food and Drug Administration (FDA). Merck expects the FDA’s review to be completed in the first half of 2013.

7 Jan 2013

Industry sponsored drug and device studies: an interview with Professor Lisa Bero

Our review included analyses of drug and device studies conducted in humans. The drugs or devices could be compared to placebo or sham treatments, or other effective treatments. The drugs and devices examined for this review are used for a wide variety of clinical conditions, including cardiovascular and psychiatric diseases.

7 Jan 2013

Viewpoints: 'Class war' over Medicare funding; GOP needs courage to cut entitlements in debt fight

Failure to curb our deficits and reform unsustainable entitlement spending means passing greater debt burdens on to future generations. Democrats and Republicans have the opportunity to reverse this trend and claim credit. ... Sadly, the deal struck this week in Congress maintains the trend of $1 trillion deficits for at least another year while continuing to ensure that federal health care spending a generation from now will be untenable.

7 Jan 2013

New research reveals a shared genetic susceptibility to epilepsy and migraine

New research reveals a shared genetic susceptibility to epilepsy and migraine. Findings published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), indicate that having a strong family history of seizure disorders increases the chance of having migraine with aura (MA).

7 Jan 2013

Biogen Idec files rFIXFc BLA with FDA for treatment of hemophilia B

Today Biogen Idec announced the company recently submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B.

7 Jan 2013

Researchers discover new pathway to reduce paradoxical pain

For individuals with agonizing pain, it is a cruel blow when the gold-standard medication actually causes more pain. Adults and children whose pain gets worse when treated with morphine may be closer to a solution, based on research published in the January 6 on-line edition of Nature Neuroscience.

7 Jan 2013

Obesity impact on lumbar disc herniation management confirmed

Obese patients with symptomatic lumbar disc herniation are significantly more likely to opt for surgery than their healthy weight counterparts but derive less benefit, SPORT findings suggest.

4 Jan 2013

Stanford scientists identify molecular basis for hypertrophic cardiomyopathy

When a young athlete dies unexpectedly on the basketball court or the football field, it's both shocking and tragic. Now Stanford University School of Medicine researchers have, for the first time, identified the molecular basis for a condition called hypertrophic cardiomyopathy that is the most common cause for this type of sudden cardiac death.

4 Jan 2013

Statin therapy affects muscles’ energy production

Up to 75 per cent of patients who take statins to treat elevated cholesterol levels may suffer from muscle pain. Scientists at the Center for Healthy Aging at the University of Copenhagen have now identified a possible mechanism underlying this unfortunate side effect.

4 Jan 2013

Markey practitioner receives Lexington Cancer Foundation grant to continue JSJ program

The University of Kentucky Markey Cancer Center's Jennifer Bradley has received funding from the Lexington Cancer Foundation to continue the Jin Shin Jyutsu program in 2013.

4 Jan 2013

FDA clears Soft Tissue Regeneration’s STR GRAFT

Soft Tissue Regeneration, an early stage orthopedic device company that has developed a breakthrough tissue engineering platform used to regenerate ligaments and tendons, announced today that it has received FDA clearance to market its STR GRAFT, a biodegradable scaffold used for soft tissue augmentation and rotator cuff repair.

3 Jan 2013

Service integration promotes viable outpatient palliative care

Healthcare reforms that promote integration of care across treatment settings facilitate feasible and cost-effective outpatient palliative care, suggest findings from a sustainable community-based model of care.

3 Jan 2013

Itch-specific nerve cells in skin discovered by John Hopkins scientists

Johns Hopkins researchers have uncovered strong evidence that mice have a specific set of nerve cells that signal itch but not pain, a finding that may settle a decades-long debate about these sensations, and, if confirmed in humans, help in developing treatments for chronic itch, including itch caused by life-saving medications.

3 Jan 2013

Pain News and Research

Latest Pain News and Research

Primary-care clinic treatment improves patient follow up

Viewpoints: Rove says GOP unlikely to make much 'structural change' to entitlements; Roe anniversary and fading public understanding; Fast food workers' health insurance

LM11A-31 effective at improving limb movement after spinal cord injury in mice

CTI initiates enrollment in pacritinib Phase 3 trial for myelofibrosis

Chronic neck pain patients show respiratory weakness

Sonoma launches VELOX procedure for repairing clavicle fractures with Sonoma CRx device

Spectrum Pharmaceuticals reveals positive RenaZorb Phase 1 clinical trial results

Merck’s resubmission of the NDA for suggammadex sodium injection accepted for review by the FDA

Industry sponsored drug and device studies: an interview with Professor Lisa Bero

Viewpoints: 'Class war' over Medicare funding; GOP needs courage to cut entitlements in debt fight

New research reveals a shared genetic susceptibility to epilepsy and migraine

Biogen Idec files rFIXFc BLA with FDA for treatment of hemophilia B

Researchers discover new pathway to reduce paradoxical pain

Obesity impact on lumbar disc herniation management confirmed

Stanford scientists identify molecular basis for hypertrophic cardiomyopathy

Statin therapy affects muscles’ energy production

Markey practitioner receives Lexington Cancer Foundation grant to continue JSJ program

FDA clears Soft Tissue Regeneration’s STR GRAFT

Service integration promotes viable outpatient palliative care

Itch-specific nerve cells in skin discovered by John Hopkins scientists

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Pain News and Research

Latest Pain News and Research

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Newsletters you may be interested in